Application of 1,3-bis(benzoyloxy)-4-(acetyl amino) benzene as well as derivative thereof
A technology of acetylamino and benzoyloxy, which is applied in the field of biomedicine, can solve the problems of high preparation cost and high price of finished drugs, and achieve the effects of simple preparation method, good therapeutic effect and abundant sources
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Example 1 checks the molecular activity of 1,3-bis(benzoyloxy)-4-(acetylamino)benzene
[0020] The materials used are 1,3-bis(benzoyloxy)-4-(acetylamino)benzene, BMS-202 (PD-L1 small molecule inhibitor published in recent years), PD-1 protein, PD-L1 protein and the HTRF kit.
[0021] Firstly, the relationship between the substrate protein concentration was tested, and the effect of different concentrations of PD-L1 on the 665 / 620nm absorbance ratio was determined under the condition of PD-1 concentration of 100nM, and the model was established.
[0022] The experimental results are shown in the table.
[0023] PDL1 (nM)
0
0.13
0.25
0.5
1.0
2.0
4.0
8.0
Absorbance ratio
0.11
0.30
0.32
0.42
0.49
0.53
0.54
0.54
[0024] After using the HTRF kit process to test the two inhibitors at the same concentration, use a microplate reader to detect the absorbance values at 665nm and 620nm, and use...
Embodiment 2
[0026] Example 2 checks the molecular activity of 1,3-bis(benzoyloxy)-4-(acetylamino)benzene derivatives
[0027] Chemically modify 1,3-bis(benzoyloxy)-4-(acetylamino)benzene, and oxidize its only aldehyde group to a carboxyl group. The synthesis method is as follows: 5g of 1,3-bis(benzoyl Acyloxy)-4-(acetylamino)benzene was dissolved in 30mL of benzene, and 20mL of 4% KMnO was added 4 solution, then add 10mL 1M dilute sulfuric acid, and react at room temperature. After 10h, the target modification (ms: 391.4) was obtained by recrystallization.
[0028] The molecular activity test of Example 1 was carried out on the modified product. It was found that the inhibitory rate of modification 1 on the binding of PD-1 and PD-L1 was 62.61%, which proved that 1,3-bis(benzoyloxy)-4-(acetylamino)benzene can improve the activity through certain modifications .
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

